Home LiteratureArticle Details
PMID: 3983638 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Genetic origin of mutations predisposing to retinoblastoma.

Science (New York, N.Y.) ·Vol. 228 ·No. 4698 ·1985-04-26 ·Pages 501-3

Cavenee WK, Hansen MF, Nordenskjold M, Kock E, Maumenee I, Squire JA, Phillips RA, Gallie BL

Abstract

Retinoblastoma is one of several human tumors to which predisposition can be inherited. Molecular genetic analysis of several nonheritable cases has led to the hypothesis that this tumor develops after the occurrence of specific mitotic events involving human chromosome 13. These events reveal initial predisposing recessive mutations. Evidence is presented that similar chromosomal events occur in tumors from heritable cases. The chromosome 13 found in the tumors was the one carrying the predisposing germline mutation and not the homolog containing the wild-type allele at the Rb-1 locus. These results suggest a new approach for identifying recessive mutant genes that lead to cancer and a conceptual basis for accurate prenatal predictions of cancer predisposition.

MeSH Terms
Alleles Chromosome Deletion Chromosome Mapping Chromosomes, Human, 13-15 Eye Neoplasms/genetics Female Heterozygote Homozygote Humans Male Mitosis Models, Genetic Mutation Pedigree Retinoblastoma/genetics
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Cavenee W K
Hansen M F
Nordenskjold M
Kock E
Maumenee I
Squire J A
Phillips R A
Gallie B L
Article Info
Journal
Science (New York, N.Y.)
Abbr.
Science
ISSN
0036-8075
Published
1985-04-26
Pages
501-3
Language
English
Region
United States
NLM ID
0404511
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com